Given the central role of LSM2 in RNA processing and the critical nature of RNA splicing in tumourigenesis, we hypothesise that LSM2 plays a crucial role in glioma progression by modulating RNA splicing events, thereby contributing to tumour aggressiveness and poor patient prognosis. This evidence concerns the gene LSM2 and glioma.